myo-, chiro- and scyllo-inositol degradation
Morinaga T, Ashida H, Yoshida KI. Identification of two scyllo-inositol dehydrogenases in Bacillus subtilis. Microbiology (Reading). 2010 May;156(Pt 5):1538–46. doi: 10.1099/mic.0.037499-0. PMID: 20133360.; Yoshida K, Yamaguchi M, Morinaga T, Kinehara M, Ikeuchi M, Ashida H, Fujita Y. myo-Inositol Catabolism in Bacillus subtilis. Journal of Biological Chemistry. 2008 Apr;283(16):10415–24. doi: 10.1074/jbc.m708043200.; Yoshida K, Yamaguchi M, Morinaga T, Ikeuchi M, Kinehara M, Ashida H. Genetic Modification of Bacillus subtilis for Production of d - chiro -Inositol, an Investigational Drug Candidate for Treatment of Type 2 Diabetes and Polycystic Ovary Syndrome. Appl Environ Microbiol. 2006 Feb;72(2):1310–5. doi: 10.1128/aem.72.2.1310-1315.2006.; Zhang R-, Dementieva I, Duke N, Collart F, Quaite-Randall E, Alkire R, Dieckman L, Maltsev N, Korolev O, Joachimiak A. Crystal structure of Bacillus subtilis ioli shows endonuclase IV fold with altered Zn binding. Proteins. 2002 Jun 05;48(2):423–6. doi: 10.1002/prot.10159.; Ramaley R, Fujita Y, Freese E. Purification and properties of Bacillus subtilis inositol dehydrogenase. Journal of Biological Chemistry. 1979 Aug;254(16):7684–90. doi: 10.1016/s0021-9258(18)36000-9.